Document Detail

Age and Risks of FDA-Approved Long-Acting {beta}2-Adrenergic Receptor Agonists.
MedLine Citation:
PMID:  22025595     Owner:  NLM     Status:  Publisher    
Objective:To determine the risk, by age group, of serious asthma-related events with long-acting β(2)-adrenergic receptor agonists marketed in the United States for asthma.Methods:The US Food and Drug Administration performed a meta-analysis of controlled clinical trials comparing the risk of LABA use with no LABA use for patients 4 to 11, 12 to 17, 18 to 64, and older than 64 years old. The effects of age on a composite of asthma-related deaths, intubations, and hospitalizations (asthma composite index) and the effects of concomitant inhaled corticosteroid (ICS) use were analyzed.Results:One hundred ten trials with 60 954 patients were included in the meta-analysis. The composite event incidence difference for all ages was 6.3 events per 1000 patient-years (95% confidence interval [CI]: 2.2-10.3) for using LABAs compared with not using LABAs. The largest incidence difference was observed for the 4- to 11-year age group (30.4 events per 1000 patient-years [95% CI: 5.7-55.1]). Differences according to age were statistically significant (P = .020). Results for the subgroup of patients with concomitant ICS use (n = 36 210) were similar to the overall results; with assigned ICSs (n = 15 192), the incidence difference was 0.4 events per 1000 patient-years (95% CI: -3.8 to 4.6), and there was no statistically significant difference according to age group.Conclusions:The excess of serious asthma-related events attributable to LABAs was greatest among children. Additional data are needed to assess risks of LABA use for children with simultaneous ICS use.
Ann W McMahon; Mark S Levenson; Bradley W McEvoy; Andrew D Mosholder; Dianne Murphy
Related Documents :
6746225 - Transsexualism and slater's selective vocabulary test.
2928445 - Comparing 16 pf scores for two groups of offenders.
18653055 - A survey of a centenarian population in italy, focusing on self-sufficiency and cognition.
7110865 - Comparison of educationally handicapped students scores on the revised developmental te...
182625 - An anatomicopathological approach to the study of articular aging.
24016245 - The changes in age of peak swim speed for elite male and female swiss freestyle swimmer...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-24
Journal Detail:
Title:  Pediatrics     Volume:  -     ISSN:  1098-4275     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Office of Pediatric Therapeutics, Office of the Commissioner, Food and Drug Administration, Silver Spring, Maryland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reducing PICU Central Line-Associated Bloodstream Infections: 3-Year Results.
Next Document:  Reducing Bloodstream Infections in Pediatric Rehabilitation Patients Receiving Parenteral Nutrition.